Advanced Biobanking and Biotechnology

Fertility biobanks

Fertility preservation is the effort to help cancer patients retain their fertility, or ability to procreate. Research into how cancer affects reproductive health and preservation options are growing, sparked in part by the increase in the survival rate of cancer patients. The main methods of fertility preservation are ovarian protection by GnRH agonists, cryopreservation of ovarian tissue, eggs or sperm, or of embryos after in vitro fertilization. The patient may also choose to use egg or sperm from a donor by third party reproduction rather than having biological children.

ART World Congress Symposium on Safe and Efficient IVF New York City, USA, Global Biobanking London, UK, The Biomarker Conference Orlando, Florida, USA, World Conference on Regenerative Medicine 2015 Leipzig, Germany, ESBB conference Johannesburg, South Africa, World Conference on Regenerative Medicine 2015 Leipzig Germany, Keystone Stem Cells and Regeneration in the Digestive Organs (X6) Keystone, Colorado, USA, Molecular and Cellular Basis of Growth and Regeneration (A3) Breckenridge, Colorado, USA, Keystone Cardiac Development, Regeneration and Repair (Z2) Snowbird, Utah, USA, Tissue Niches & Resident Stem Cells in Adult Epithelia Gordon Research Conference Hong Kong, China.

According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver for biobanks, hospitals and gene banks, which are the major end-user segments of the biopreservation media & equipment market.